Veru says veru-111 reduced key cytokines involved in acute respiratory distress syndrome in covid-19 in toxic shock model

Veru-111 suppresses key cytokines responsible for severe acute respiratory distress syndrome in covid-19.veru inc - veru-111 significantly reduced key cytokines involved in acute respiratory distress syndrome in covid-19 in a toxic shock model.veru inc - phase 2 clinical study in hospitalized covid-19 patients at high risk for acute respiratory distress syndrome actively enrolling patients.veru inc - veru-111's ability to disrupt microtubules has potential for dual drug action against covid-19.
VERU Ratings Summary
VERU Quant Ranking